ARQT three-lens brief
Evidence-based stock research on ARQT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 20.0pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 20.0pp over 30 days.
- P/E of 106 — priced for high growth; little margin of safety.
- Analyst mean target $36.88 — 58% above current (8 analysts).
ARQT closed at $23.38 (-1.93%) as of 2026-09-11. Market cap: $2.94B. P/E (trailing) 106.3. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $36.88 — 58% above current (8 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 20.0pp over 30 days.. Last quarter: Revenue $129.86M, net income $15.01M, free cash flow $21.69M.
Why three lenses on ARQT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARQTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARQT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARQT brief"></iframe>